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PURPOSE
The purpose of this study is to determine patient satisfaction
after being counseled by a pharmacist as well as to see if education
decreased any hospitalizations while the patient was receiving
treatment.

Question 1: I felt very knowledgeable about
my chemotherapy regimen before the
pharmacist counseled me
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BACKGROUND
Cancer is increasing worldwide and more and more people
have received chemotherapy treatment. Chemotherapy agents
are cytotoxic drugs that kill cancer cells. Due to the increase in
cancer, there has also been in an increase in research for cancer
medications. For most people, the diagnosis of cancer causes
many psychological and emotional effects which make it difficult to
accept the ramifications of disease and treatment process. There
are several support groups that patients can attend, but studies
have shown that educating patients about cancer and
chemotherapy in general can increase the patient’s compliance
and satisfaction as well as decrease side effects and
hospitalizations. Pharmacists can offer teaching and education to
these patients and their families to help decrease anxiety and
complications.1
.

METHODS

This was a single center, prospective, survey-based study at a
small community hospital infusion center that consists of
approximately five chairs. An oncology pharmacy specialist was
available to provide counseling and education to patients while in
the infusion center three days of the week. When the oncology
specialist was unavailable, counseling was performed by other
clinical specialists on staff. A standard chemotherapy handout was
developed and one website (www.chemocare.com) was used to
print drug handouts for patients. All clinical specialists at the
hospital received training on the use of these handouts.
The study consisted of 15 patients, over the course of six
months (April-October 2016). Counseling and education was
completed at the beginning and middle of each patient’s
chemotherapy cycle. At the end of the cycle, a Likert-scale and
short answer survey was administered to determine patient
satisfaction and whether any hospitalizations occurred.
All patients participating in the study were asked for permission to
be counseled and whether they would want to fill out the survey at
the end of their cycle. To be included in the study, patients only
had to receive chemotherapy in the infusion center being studied.

CONCLUSIONS

RESULTS
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Question 2: I felt knowledgeable about
my chemotherapy regimen after the
pharmacist counseled me
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Question 3: I knew exactly what to do when I
had any side effects
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New and complicated chemotherapy regimens require educated
physicians, nurses, and pharmacists for patient counseling.
Oncology pharmacists’ counseling plays a key role in patient
education. Based on the results of the survey, patients at North
Fulton Hospital felt confident in their knowledge of the
chemotherapy regimen, of what to do in the occurrence of side
effects, and how/why their drugs work. In regards to Emergency
Department admissions, half of them were “good admissions”
based on pharmacists’ recommendations; and the other half were
before counseling, due to patient non adherence to
recommendations or uncontrolled antiemetic therapy.

Question 4: The pharmacist helped my
understand exactly why and how the drugs
worked
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Eight patients completed the survey from the fifteen total patients enrolled. The results are shown above.
Figure 1: ED Admission Status

Figure 2: Type of ED Admission
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Some limitations of this study include the small population,
various pharmacists giving counseling information, and not every
pharmacist who counseled was trained in oncology. Time was
also a limitation for many pharmacists due to their other clinical
responsibilities, so some patients we not counseled until the 2nd
or 3rd cycle of chemotherapy. If oncology patients were admitted
to any other ED than North Fulton without relaying this
information, these admissions may not have been included in the
study for lack of knowledge. If patients reported side effects to
their oncologists only, there was no direct communication
between pharmacy and oncologists, so these side effects may be
missed in reporting.
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Nine patients were analyzed for Emergency Department (ED) admissions. A “good admission” was considered an
admission to the ED in which patients had followed counseling to remain at home up to the point of admission being
required based on pharmacist’s previous recommendations. A “bad admission” was considered an admission that
could have been prevented by adhering to pharmacist counseling or receiving pharmacist counseling before
chemotherapy.
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